2Knight WA,Livingston RB,Gregory EJ,et al.Estrogen re-cepetor as an independent prognostic factor for carly recurrence in breast[J].Cancer Res,1977,37(13):4669.
二级参考文献2
1Michael Gershanovich,August Garin,Dace Baltina,Ants Kurvet,Lauri Kangas,Juha Ellmén,Eastern European Study Group. A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer[J] 1997,Breast Cancer Research and Treatment(3):251～262
2Lazzaro Repetto,Pier Giorgio Giannessi,Elisabetta Campora,Paolo Pronzato,Antonella Vigani,Cinzia Naso,Italo Spinelli,Pier Franco Conte,Riccardo Rosso. Tamoxifen and interferon-beta for the treatment of metastatic breast cancer[J] 1996,Breast Cancer Research and Treatment(2):235～238
6Duraker N, Bati B, Demir D, et al. Prognostic significance of the number of removed and metastatic lymph nodes andlymph node ra- tio in breast carcinoma patients with 1 -3 axillary lymph node(s)metastasis[ J]. ISRN 0ncol,2011,4:645 - 650.
7Ng CH, Pathy NB, Taib NA, et al. The estrogen receptor negative progesterone receptor positive breast carcinoma is a biological entity and not a technical artifact[J]. Asian Pac J Cancer Prey,2012,13 (4) :1111 -1113.
8Wiechmann L, Sampson M, Stempel M, et al. Presenting features of breast cancer differ by molecular subtype [ J ]. Ann Surg Oncol, 2009,16(10) :2705 -2710.
9Zhao J, Liu H, Wang M, et al. Characteristics and prognosis for mo- lecular breast cancer subtypes in Chinese women [ J ]. J Surg 0n- col,2009,100(2) :89 -94.
10Rakha EA, E1 - Sayed ME, Green AR, et al. Prognostic markers in triple - negative breast cancer [ J ]. Cancer, 2007,109 ( 1 ) : 25 - 32.
